TCL Archive DCE Board Sets Aside $2 Million For Radiation Grants Program; Okays Concept For Add-On To ASCUS Trial October 13, 1995
TCL Archive Also NSABP’s STAR Trial Finds Raloxifene Equivalent To Tamoxifen For Breast Cancer Risk Reduction. April 21, 2006
TCL Archive Also in this 8-page issue: American Legacy Foundation calls Time Inc. a “hero” of tobacco control, but antismoking activists see villain. Time Inc. and parent Time Warner hasn’t made progress in reducing tobacco advertising in magazines, movies, researchers say. March 4, 2005
